Renal toxicity reported in patients with liver dysfunction receiving oral cholecystographic agent followed by iodixanol. Postpone iodixanol administration in patients who recently received oral cholecystographic contrast.
Source: NLP:iodixanol
Oral Cholecystographic Contrast Agents Interactions
3 interactions on record
Iodine-containing agents may decrease or increase thyroid hormone secretion. Parenterally administered agents cause shorter duration effects than oral cholecystographic agents.
Source: NLP:levothyroxine sodium
Radiographic contrast agent that interferes with radioiodide accumulation. Discontinue 6 months before procedure.
Source: NLP:sodium iodide i 131